Kinnate Biopharma Inc. (KNTE) has a market capitalization of $124.99M and trades at $2.65. The 52-week range is 1.04-7.185.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-2.42.
The stock has a beta of 1.34, operates in the Healthcare sector.
